4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-021271
CHIEF OPERATING OFFICER sold 138,614 shares at an average $33.20 ($4,602,370)
- CHIEF OPERATING OFFICER acquired 138,614 shares (option exercise)
- CHIEF OPERATING OFFICER acquired 752 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-07-15 | Grant or award 10b5-1 | +752 | $15.63 | $11,754 | 49,915 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Option exercise 10b5-1 | +38,928 | $10.36 | $403,294 | 88,843 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Option exercise 10b5-1 | +30,444 | $12.97 | $394,859 | 119,287 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Option exercise 10b5-1 | +32,710 | $11.10 | $363,081 | 151,997 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Option exercise 10b5-1 | +25,896 | $11.97 | $309,975 | 177,893 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Option exercise 10b5-1 | +10,636 | $10.76 | $114,443 | 188,529 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Sale 10b5-1 | −138,064 | $33.20 | $4,583,725 | 50,465 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Sale 10b5-1 | −550 | $33.90 | $18,645 | 49,915 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Option exercise · Share Option 10b5-1 | −38,928 | 0 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Option exercise · Share Option 10b5-1 | −30,444 | 16,694 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Option exercise · Share Option 10b5-1 | −32,710 | 32,710 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Option exercise · Share Option 10b5-1 | −25,896 | 39,524 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-05 | Option exercise · Share Option 10b5-1 | −10,636 | 31,908 | D | ||
| Open-market sales · 138,614 sh · avg $33.20 · $4,602,370 | |||||||
Loading xslF345X05/form4-08072025_080818.xml…